Cargando…
Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study
BACKGROUND: China contributes to a significant proportion of the myopia in the world. The study aims to investigate the utilization of various correction methods and health service in urban China, and to estimate the cost of myopia treatment and prevention. In addition, we aimed to estimate the cost...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Global Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934110/ https://www.ncbi.nlm.nih.gov/pubmed/35356656 http://dx.doi.org/10.7189/jogh.12.11003 |
_version_ | 1784671792387850240 |
---|---|
author | Ma, Yingyan Wen, Yuechun Zhong, Hua Lin, Senlin Liang, Li Yang, Yifang Jiang, Huifen Chen, Jian Huang, Yan Ying, Xiaohua Resnikoff, Serge Lu, Lina Zhu, Jianfeng Xu, Xun He, Xiangui Zou, Haidong |
author_facet | Ma, Yingyan Wen, Yuechun Zhong, Hua Lin, Senlin Liang, Li Yang, Yifang Jiang, Huifen Chen, Jian Huang, Yan Ying, Xiaohua Resnikoff, Serge Lu, Lina Zhu, Jianfeng Xu, Xun He, Xiangui Zou, Haidong |
author_sort | Ma, Yingyan |
collection | PubMed |
description | BACKGROUND: China contributes to a significant proportion of the myopia in the world. The study aims to investigate the utilization of various correction methods and health service in urban China, and to estimate the cost of myopia treatment and prevention. In addition, we aimed to estimate the cost of productivity loss due to myopia. METHODS: The study was a cross-sectional investigation carried out in urban areas in three provinces located in the east (Shanghai), middle (Anhui) and west part (Yunnan) of China, in 2016. A total of 23819 people aged between 5 to 50 years were included. Health utilization and the cost of myopia were analyzed from patients’ perspective. RESULTS: The total number of people with myopia in the urban China was estimated to be 143.6 million. The correction rate was 89.5%, 92.1%, and 92.7% for Anhui, Shanghai, and Yunnan (χ(2) = 19.5, P < 0.01). Over the recent year, 20.6%, 16.8%, and 28.8% of myopic subjects visited hospital due to myopia, in Anhui, Shanghai and Yunnan. The annual cost of treatment and prevention of myopia was 10.1 billion US dollar (US$, floating from 9.2 to 11.2 billion US$), and the cost per person was 69US$. The annual cost of loss of productivity was estimated to be 6.7 billion US$ for those with mild to moderate visual impairment (floating from 6.1 to 7.4 billion US$), and 9.4 billion US$ (floating from 8.5 to 10.4 billion US$) for those with severe visual impairment to blindness. Therefore, the total economic burden of myopia was estimated as 173.6 billion CNY (26.3 billion US$). CONCLUSIONS: The present study shows that myopia leads to substantial economic burden in China. The loss of productivity caused by myopia is an important part of the disease burden compared to the cost of correction and treatment paid by individuals. Therefore, the focus of myopia prevention and control should be to decrease the myopia prevalence, and prevent the uncorrected refractive errors and the irreversible damage of visual acuity by high myopia. |
format | Online Article Text |
id | pubmed-8934110 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | International Society of Global Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-89341102022-03-29 Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study Ma, Yingyan Wen, Yuechun Zhong, Hua Lin, Senlin Liang, Li Yang, Yifang Jiang, Huifen Chen, Jian Huang, Yan Ying, Xiaohua Resnikoff, Serge Lu, Lina Zhu, Jianfeng Xu, Xun He, Xiangui Zou, Haidong J Glob Health Research Theme 7: Health Transitions in China BACKGROUND: China contributes to a significant proportion of the myopia in the world. The study aims to investigate the utilization of various correction methods and health service in urban China, and to estimate the cost of myopia treatment and prevention. In addition, we aimed to estimate the cost of productivity loss due to myopia. METHODS: The study was a cross-sectional investigation carried out in urban areas in three provinces located in the east (Shanghai), middle (Anhui) and west part (Yunnan) of China, in 2016. A total of 23819 people aged between 5 to 50 years were included. Health utilization and the cost of myopia were analyzed from patients’ perspective. RESULTS: The total number of people with myopia in the urban China was estimated to be 143.6 million. The correction rate was 89.5%, 92.1%, and 92.7% for Anhui, Shanghai, and Yunnan (χ(2) = 19.5, P < 0.01). Over the recent year, 20.6%, 16.8%, and 28.8% of myopic subjects visited hospital due to myopia, in Anhui, Shanghai and Yunnan. The annual cost of treatment and prevention of myopia was 10.1 billion US dollar (US$, floating from 9.2 to 11.2 billion US$), and the cost per person was 69US$. The annual cost of loss of productivity was estimated to be 6.7 billion US$ for those with mild to moderate visual impairment (floating from 6.1 to 7.4 billion US$), and 9.4 billion US$ (floating from 8.5 to 10.4 billion US$) for those with severe visual impairment to blindness. Therefore, the total economic burden of myopia was estimated as 173.6 billion CNY (26.3 billion US$). CONCLUSIONS: The present study shows that myopia leads to substantial economic burden in China. The loss of productivity caused by myopia is an important part of the disease burden compared to the cost of correction and treatment paid by individuals. Therefore, the focus of myopia prevention and control should be to decrease the myopia prevalence, and prevent the uncorrected refractive errors and the irreversible damage of visual acuity by high myopia. International Society of Global Health 2022-03-19 /pmc/articles/PMC8934110/ /pubmed/35356656 http://dx.doi.org/10.7189/jogh.12.11003 Text en Copyright © 2022 by the Journal of Global Health. All rights reserved. https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License. |
spellingShingle | Research Theme 7: Health Transitions in China Ma, Yingyan Wen, Yuechun Zhong, Hua Lin, Senlin Liang, Li Yang, Yifang Jiang, Huifen Chen, Jian Huang, Yan Ying, Xiaohua Resnikoff, Serge Lu, Lina Zhu, Jianfeng Xu, Xun He, Xiangui Zou, Haidong Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study |
title | Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study |
title_full | Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study |
title_fullStr | Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study |
title_full_unstemmed | Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study |
title_short | Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study |
title_sort | healthcare utilization and economic burden of myopia in urban china: a nationwide cost-of-illness study |
topic | Research Theme 7: Health Transitions in China |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934110/ https://www.ncbi.nlm.nih.gov/pubmed/35356656 http://dx.doi.org/10.7189/jogh.12.11003 |
work_keys_str_mv | AT mayingyan healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy AT wenyuechun healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy AT zhonghua healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy AT linsenlin healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy AT liangli healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy AT yangyifang healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy AT jianghuifen healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy AT chenjian healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy AT huangyan healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy AT yingxiaohua healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy AT resnikoffserge healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy AT lulina healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy AT zhujianfeng healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy AT xuxun healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy AT hexiangui healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy AT zouhaidong healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy |